Premium Content

Navigating MIPS: Why MIPS matters and how to reportMIPS involves over 378 measures and activities- but this infographic breaks it down.
Drug Topics Perspectives: Do your distributors’ interests conflict with yours?
All Healthcare is not Local The Human Cost of Disparate Health DataCan you access patient data from outside systems within your existing EHR workflow? Now you can. Read how a truly national record locator service improves patient care coordination and positively impacts care quality.
Effective Lice Management in the Era of Pesticide-ResistanceAre you prepared to recommend a solution that is safe, quick, and effective in getting lice out of hair and families back to their normal routines?
Increasing The Value of a Practice through Targeted Patient EngagementRead this whitepaper to learn about more effective strategies to increase patient engagement and add value to your practice.
Current Approaches in the Management of Glaucoma PatientsExplore factors affecting patient compliance.
Long-acting reversible contraceptionAddressing knowledge gaps and misperceptions
All Healthcare is not Local: The Human Cost of Disparate Health DataTo address rising healthcare costs, clinicians have experienced countless shifting demands and requirements over the past decade. While there’s no single solution to address all of the issues that contribute to rising costs, improving care coordination across the healthcare continuum has the potential to dramatically improve patient care, reduce duplicative tests and procedures, and positively impact care quality – saving an estimated $148 billion to $226 billion annually.
The Toxin Head-to-Head ChallengeFor answers, Dermatology Times and Cosmetic Surgery Times developed an online survey for readers. The activity presented images from 6 patients who were photographed on the day of their injection and 30 days after treatment with either Xeomin® (incobotulinumtoxinA, Merz Pharmaceuticals) or Botox® (onabotulinumtoxinA, Allergan).
Whitepaper: Patient-Focused Solutions for Higher Value Care in the Specialty Drug MarketThis whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.